Brief: Iterum Therapeutics reports Q2 results
12/08/2022 12:08
Aug 12 (Reuters) - Iterum Therapeutics PLC ITRM.O :
* ITERUM THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
* ITERUM THERAPEUTICS PLC - CASH, CASH EQUIVALENTS AND
SHORT-TERM
INVESTMENTS WAS $68.9 MILLION AT JUNE 30, 2022
* ITERUM THERAPEUTICS PLC - QTRLY LOSS PER SHARE $0.04
* ITERUM THERAPEUTICS PLC - QTRLY ADJUSTED LOSS PER SHARE
$0.03
Source text for Eikon: ID:nGNXbsFbvV
Further company coverage: ITRM.O
Recent news on Iterum Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Entergy, US natgas stocks, Brown-Forman, Datacentrex
U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
Iterum Therapeutics plummets after filing wind up petition
Iterum seeks court-led dissolution amid cash crisis, inability to raise funds (updated)
Iterum files wind-up petition due to limited cash, inability to raise equity